« Return to News | Drug Sponsors | CROs/Service Providers

INC Research Launches Alliance Partnerships Program

Wednesday, February 24, 2010 06:45 AM

Raleigh, N.C.-based CRO INC Research launched an alliance partnerships program to create and manage strategic alliances with pharmaceutical and biotech customers. The company said it hopes to create relationships with customers based on joint strategic objectives rather than service agreements.

The services provided by INC through these relationships can include complete management of a compound or therapeutic area, management of a specific function or set of critical processes, sharing in the risk and reward of a compound's performance, or acting as the sole source development partner for a customer. Tim Dietlin was appointed vice president, alliance development, to oversee the effort.

“Drug developers are starting to realize that the traditional role of a preferred CRO provider is not producing the financial, efficiency and quality benefits they had hoped for,” said INC Research’s executive vice president of strategic development Alistair Macdonald in a statement. “We want to take these relationships to the next level by developing commercial level solutions supported by our excellence in clinical trial execution.”

Quintiles launched a similar effort earlier this year, which recently resulted in a commercialization deal with Belgian pharma company Movetis.

Share:          
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

September 30

Novartis-Walgreens pilot study blurring the line between retail pharmacy, investigative site

CISCRP to launch traveling science museum exhibit to demystify clinical trial participation

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

October

New growth and decline in Asia clinical trials
South Korea, Japan, China see big growth in 1572s, while India posts huge drop

Harnessing Big Data to transform clinical trials
From protocol to patient recruiting, data analytics can yield valuable insights

Already a subscriber?
Log in to your digital subscription.

Purchase the October issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

September

Sponsors look to collaborate on comparator drugs
Co-therapies, comparators are in 60% of studies, cost $25m per company a year

Early adopters implement risk-based monitoring pilot programs
Experiments aim to offer long-term solutions, despite short-term uncertainties

Already a subscriber?
Log in to your digital subscription.

Purchase the September issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs

More Jobs

 

Copyright © 1995-2013 CenterWatch.